The last three years have been anything but static for next-generation sequencing (NGS) companies. Several competitors have launched new sequencing technologies that have taken direct, and often ...

MENLO PARK, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- PacBio (PACB), a leading developer of high-quality, highly accurate genomic sequencing solutions, today announced the inclusion of the Onso ...

Welcome to a new era for clinical labs. The NovaSeq ™ 6000Dx is Illumina's first IVD high-throughput sequencing instrument for the clinical lab. Push the boundaries of clinical genomics with scalable ...

MENLO PARK, Calif., Aug. 2, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced that customer shipments of Onso short-read ...

Illumina, Inc. ILMN recently launched the Global Health Access Initiative to support the acceleration of pathogen sequencing in low and middle-income countries (LMICs). The program aims to provide ...

Next-generation sequencing (NGS) has moved away from expensive runs and complicated workflows into a new era where benchtop instruments prioritize sustainability, accessibility, accuracy, and speed.

As the current leader in genomic sequencing, Although Illumina management's preview of 20% revenue growth and adjusted earnings per share of $3.12-$3.18 for 2015 falls modestly below our expectations, ...

The answer depends on the questions you’re trying to answer, as well as the origin, quantity, and quality of your samples. In this article, we’ll briefly discuss several RNA-seq workflows, how they ...

The Advances in Genome Biology and Technology (AGBT) meeting celebrated its 25 th anniversary in sunny Marco Island, Florida, with the customary mix of big name speakers addressing researchers and ...